Xlrl inhibitors are chemical compounds specifically designed to target and inhibit the Xlrl protein, a member of a protein family involved in key regulatory processes within cells. Although Xlrl is not fully characterized, it is believed to play a role in gene expression regulation, intracellular signaling, and possibly cellular structural maintenance. Proteins like Xlrl are typically associated with binding to nucleic acids or interacting with other regulatory proteins, thus influencing transcriptional processes and contributing to the control of various cellular functions. Xlrl may also be involved in modulating cellular responses to environmental stimuli, acting as a mediator in pathways that regulate the flow of information between the cell's internal and external environments.
Inhibitors of Xlrl function by binding to specific active or regulatory sites on the protein, preventing it from executing its biological role in these pathways. By blocking Xlrl's activity, these inhibitors can interfere with cellular processes such as gene expression, protein synthesis, or intracellular communication. This disruption may have downstream effects on a variety of cellular mechanisms, including the regulation of cell growth, differentiation, and stress responses. Understanding the structural and functional properties of Xlrl inhibitors, including their precise interaction sites and the changes they induce in Xlrl, is critical for exploring how these compounds modulate protein function at a molecular level. Such insights provide valuable information on how Xlrl's inhibition impacts broader cellular processes, particularly those dependent on precise regulatory control of gene expression and signaling networks.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Actinomycin D inhibits gene expression by preventing RNA polymerase activity necessary for transcription. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $88.00 $200.00 | 13 | |
Triptolide inhibits RNA polymerase activity, leading to decreased transcription and potentially impacting expression of the RIKEN cDNA 3830403N18 gene. | ||||||
Rifampicin | 13292-46-1 | sc-200910 sc-200910A sc-200910B sc-200910C | 1 g 5 g 100 g 250 g | $95.00 $322.00 $663.00 $1438.00 | 6 | |
Rifampicin inhibits bacterial RNA polymerase and potentially could impact RNA polymerase activity involved in transcription of the RIKEN cDNA 3830403N18 gene. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $260.00 $1029.00 | 26 | |
α-Amanitin specifically inhibits RNA polymerase II, which is crucial for mRNA transcription, potentially affecting the expression of the RIKEN cDNA 3830403N18 gene. | ||||||
Mycophenolic acid | 24280-93-1 | sc-200110 sc-200110A | 100 mg 500 mg | $68.00 $261.00 | 8 | |
Mycophenolic acid inhibits inosine monophosphate dehydrogenase, disrupting guanine nucleotide synthesis and potentially impacting gene expression, including the RIKEN cDNA 3830403N18 gene. | ||||||
Ellipticine | 519-23-3 | sc-200878 sc-200878A | 10 mg 50 mg | $142.00 $558.00 | 4 | |
Ellipticine intercalates into DNA, leading to inhibition of RNA and DNA synthesis, potentially impacting the expression of the RIKEN cDNA 3830403N18 gene. | ||||||
Triamterene | 396-01-0 | sc-213103A sc-213103 | 1 g 5 g | $22.00 $53.00 | ||
Triamterene has been shown to inhibit RNA synthesis, potentially affecting the expression of the RIKEN cDNA 3830403N18 gene. | ||||||
Aclacinomycin A | 57576-44-0 | sc-200160 | 5 mg | $129.00 | 10 | |
Aclarubicin intercalates into DNA and inhibits topoisomerase II, potentially impacting DNA replication and transcription of the RIKEN cDNA 3830403N18 gene. | ||||||